Prothrombotic state associated with preeclampsia

Curr Opin Hematol. 2021 Sep 1;28(5):323-330. doi: 10.1097/MOH.0000000000000678.

Abstract

Purpose of review: Preeclampsia is a common complication of pregnancy and contributes significantly to maternal and fetal morbidity and mortality. A protective hypercoagulable state is often developed during late pregnancy and can evolve into a prothrombotic state in patients with preeclampsia. The underlying mechanism of this prothrombotic transition remains poorly understood. We discuss recent progress in understanding the pathophysiology of preeclampsia and associated prothrombotic state.

Recent findings: The hypercoagulable state developed during pregnancy is initiated by placental factors and progresses into the prothrombotic state in preeclampsia when the placenta is subjected ischemic and oxidative injuries. The cause of the preeclampsia-induced prothrombotic state is multifactorial, involving not only placental factors but also maternal conditions, which include genetic predisposition, preexisting medical conditions, and conditions acquired during pregnancy. Endotheliopathy is the primary pathology of preeclampsia and contributes to the prothrombotic state by inducing the dysregulation of coagulation, platelets, and adhesive ligands.

Summary: Patients with preeclampsia often develop a severe prothrombotic state that predisposes them to life-threatening thrombosis and thromboembolism during and after pregnancy. Early recognition and treatment of this prothrombotic state can improve maternal and infant outcomes of preeclampsia patients.

Publication types

  • Review

MeSH terms

  • Blood Platelets / metabolism
  • Female
  • Genetic Predisposition to Disease*
  • Humans
  • Placenta / metabolism
  • Platelet Adhesiveness
  • Pre-Eclampsia* / blood
  • Pre-Eclampsia* / genetics
  • Pregnancy
  • Pregnancy Proteins / blood
  • Pregnancy Proteins / genetics
  • Thrombosis* / blood
  • Thrombosis* / genetics

Substances

  • Pregnancy Proteins